Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
2020 · The Lancet Oncology · 314 citations
https://doi.org/10.1016/s1470-2045(20)30224-2
S
Stefano Di Sandro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
215
Papers
4.4K
Citations
30
h-index
93
i10-index
Stefano Di Sandro is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Organ Transplantation Techniques and Outcomes & Liver Disease and Transplantation. The author has an h-index of 30, co-authored 183 publications.
ORCID: 0000-0002-5217-8885Papers by this author
worksDonor safety in living donor liver donation: An Italian multicenter survey
2016 · Liver Transplantation · 74 citations
https://doi.org/10.1002/lt.24651
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series
2023 · International Journal of Infectious Diseases · 15 citations
https://doi.org/10.1016/j.ijid.2022.12.027
Portal vein thrombosis and liver transplantation: management, matching, and outcomes. A retrospective multicenter cohort study
2024 · International Journal of Surgery · 10 citations
https://doi.org/10.1097/js9.0000000000001149
Full robotic versus open ALPPS: a bi-institutional comparison of perioperative outcomes
2024 · Surgical Endoscopy · 8 citations
https://doi.org/10.1007/s00464-024-10804-z
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation
2024 · Critical Reviews in Oncology/Hematology · 6 citations
https://doi.org/10.1016/j.critrevonc.2024.104607
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat